These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16817341)

  • 21. CASRdb: calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Pidasheva S; D'Souza-Li L; Canaff L; Cole DE; Hendy GN
    Hum Mutat; 2004 Aug; 24(2):107-11. PubMed ID: 15241791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004).
    Mallet E;
    Horm Res; 2008; 69(3):180-8. PubMed ID: 18219222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypocalcemic tetany in the newborn as a manifestation of unrecognized maternal primary hyperparathyroidism.
    Pieringer H; Hatzl-Griesenhofer M; Shebl O; Wiesinger-Eidenberger G; Maschek W; Biesenbach G
    Wien Klin Wochenschr; 2007; 119(3-4):129-31. PubMed ID: 17347863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal seizures due to maternal primary hyperparathyroidism.
    Jaafar R; Yun Boo N; Rasat R; Latiff HA
    J Paediatr Child Health; 2004; 40(5-6):329. PubMed ID: 15151599
    [No Abstract]   [Full Text] [Related]  

  • 25. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
    McCann LM; Beto J
    J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neonatal tetany due to maternal calcium metabolism disorder--maternal hyperparathyroidism (parathyroid cancer) and familial idiopathic hypoparathyroidism].
    Ozeki T; Egi S; Takehiro A; Otsuka S; Egawa M
    Horumon To Rinsho; 1977 Aug; 25(8):825-9. PubMed ID: 912925
    [No Abstract]   [Full Text] [Related]  

  • 27. Disorders of the parathyroid glands.
    Hoffenberg R
    Practitioner; 1972 Mar; 208(245):360-8. PubMed ID: 4554482
    [No Abstract]   [Full Text] [Related]  

  • 28. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):798-807. PubMed ID: 19250271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Present status and problems in vitamin D and sevelamer therapy (discussion)].
    Tahara H; Yumita S; Ishida M; Tsuruta Y; Cunningham J; Fukagawa M; Tominaga Y; Tokumoto M; Onoda N
    Clin Calcium; 2005 Sep; 15 Suppl 1():225-8. PubMed ID: 16279028
    [No Abstract]   [Full Text] [Related]  

  • 30. Symptomatic hypocalcaemia in hypermagnesaemia-induced hypoparathyroidism, during magnesium tocolytic therapy--possible involvement of the calcium-sensing receptor.
    Mayan H; Hourvitz A; Schiff E; Farfel Z
    Nephrol Dial Transplant; 1999 Jul; 14(7):1764-6. PubMed ID: 10435892
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary hyperparathyroidism.
    Pahlavan PS
    Saudi Med J; 2000 Jul; 21(7):695; author reply 697. PubMed ID: 11500742
    [No Abstract]   [Full Text] [Related]  

  • 32. [Secondary and tertiary hyperparathyroidism].
    Kuriyama M; Yang M
    Nihon Rinsho; 1995 Apr; 53(4):965-7. PubMed ID: 7752493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal magnesium disturbances.
    Tsang RC
    Am J Dis Child; 1972 Aug; 124(2):282-93. PubMed ID: 4559534
    [No Abstract]   [Full Text] [Related]  

  • 34. [Primary hyperparathyroidism].
    Imanishi Y
    Nihon Rinsho; 2006 Jun; Suppl 2():5-9. PubMed ID: 16817338
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypomagnesemia in neonatal tetany associated with maternal hyperparathyroidism.
    Ertel NH; Reiss JS; Spergel G
    N Engl J Med; 1969 Jan; 280(5):260-3. PubMed ID: 5762169
    [No Abstract]   [Full Text] [Related]  

  • 37. Preoperative preparation of patients with hyperparathyroidism as comorbidity.
    Zivaljević V; Kalezić N; Jovanović D; Sabljak V; Diklić A; Paunovi I
    Acta Chir Iugosl; 2011; 58(2):109-15. PubMed ID: 21879659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital familial hypoparathyroidism. Management of an infant, genetics, pathogenesis of hypoparathyroidism, and fetal undermineralization.
    Gorodischer R; Aceto T; Terplan K
    Am J Dis Child; 1970 Jan; 119(1):74-8. PubMed ID: 5308088
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of secondary hyperparathyroidism].
    Pichlmaier H; Edel HH
    Munch Med Wochenschr; 1971 Jun; 113(23):884-7. PubMed ID: 4931694
    [No Abstract]   [Full Text] [Related]  

  • 40. Maternal and neonatal hyperparathyroidism as a consequence of maternal renal tubular acidosis.
    Savani RC; Mimouni F; Tsang RC
    Pediatrics; 1993 Mar; 91(3):661-3. PubMed ID: 8441579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.